The Impact of Intraoperative Systemic Lidocaine Infusion on Chronic Postoperative Pain After Video-assisted Thoracic Surgery (VATS)
CompletedNot applicableNCT02006966
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Systemic lidocaine infusion may improve the patients' chronic post surgical pain after video-assisted thoracic surgery
Study details
- Conditions
- Lung Cancer(Primary, Metastatic)
- Benign Lung Mass Requiring Operation
- Interventions
- Drug: Systemic intravenous lidocaine infusion
- Drug: Normal saline infusion
- Sponsor
- Yonsei University
- Start date
- 2014-01
- Primary completion
- 2016-08-22
- Sex
- All
- Age range
- from 20 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 20 and 65 years * ASA class 1 and 2 * Patients who are scheduled for video-assisted thoracic surgery Exclusion Criteria: * Allergy to local anesthetics or contraindication to use of lidocaine * Pregnancy * Severe cardiovascular disease * Renal failure * Liver failure * Neurologic and psychologic disease * Chronic treatment with analgesics or chronic pain patients * Previous history of thoracic surgery (open or video-assisted) * Patients' refusal
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02006966